Phico Therapeutics raises £7m to advance next-gen antibiotic candidate
Phico Therapeutics raises £7m to advance next-gen antibiotic candidate 11th May 2021 Cambridge, UK-based biotech company Phico Therapeutics has announced new investments of £7m, led by the UK’s most active growth capital investor BGF. The new investments closely follow the recent announcement that Phico has been awarded a grant of up to $18.2m (£13.2m) to support the development of its lead product SASPject PT3.9 from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). Phico added that the newly raised £7m will be used to support the continued development of ...
Source: pharmatimes.com